IPL Clinical Studies and
Reviews
Treatment of poikiloderma of Civatte
Weiss RA; Goldman MP; Weiss MA. Treatment of poikiloderma of Civatte with an
intense pulsed light source. Dermatol Surg 2000 Sep;26(9):823-7; discussion 828.
Abstract:
Background: Effective treatment of poikiloderma of
Civatte combines elimination of both the vascular and pigmented components
simultaneously. A broad spectrum, noncoherent, intense pulsed light (IPL) source
delivers multiple wavelengths with software controlled pulse durations and
sequencing, which permits treatment of both vascular and pigmented lesions
simultaneously. Objective: To determine response and side effects of
poikiloderma of Civatte of the neck and chest when treated by IPL.
Methods: One hundred and thirty-five patients
randomly selected with typical changes of poikiloderma of Civatte on the neck
and/or upper chest were treated with one to five treatments using IPL.
Results: Clearance of more than 75% of
telangiectasias and hyperpigmentation comprising poikiloderma was observed. The
incidence of side effects was 5%, including pigment changes. In many cases,
improved skin texture was noted both by physician and patient.
Conclusion: IPL is an effective mode of therapy for
poikiloderma of Civatte. It offers a reduction of pigment and telangiectasias
with a low risk profile. Additional benefits include subjective changes of
improvement in skin texture.
Treatment of venous malformations
Raulin C, Werner S. Treatment of venous malformations with an intense pulsed
light source (IPLS) technology: A retrospective study. Lasers Surg Med
1999;25(2):170-177.
Abstract:
Background and Objective: The intense pulsed light
source (IPLS) technology provides an innovative concept in the treatment of
vascular lesions. We investigated the effectiveness of IPLS in the treatment of
venous malformations.
Study Design/Materials and Methods: A retrospective
study of 11 patients with venous malformations (VMA) treated with IPLS was
initiated. Clinical VMA characteristics recorded were size and location. Data
collected included treatment parameters (filters, pulse duration, fluence, and
pulse sequencing), % clearance, and side effects (e.g., swelling, blisters,
crusting, pain, altered pigmentation, and scarring).
Results: Good and very good (70-100%) clearance was
achieved in 8 malformations smaller than 100 cm(2). Especially small lesions
needed only 2-3 treatments. Three VMA larger than 100 cm(2) could be cleared
well in an average of 18 sessions. The most frequently used parameters were the
590 nm filter in long pulse mode, triple pulses, and fluences at an average of
80.4 J/cm(2). Side effects included prolonged erythema in 23.6, swelling in
17.9%, crusting in 4.7%. Bleeding, hypo-, hyperpigmentation, and scarring were
rare (0.9% respectively).
Conclusion: IPLS presents an effective method for
treating VMA, especially small malformations, with a justifiable rate of side
effects when optimal parameters are chosen.
PhotoDerm VL-Flashlamp for skin lesions
Schroeter CA, Neumann HAM. An Intense Light Source: The PhotoDerm VL-Flashlamp
as a new treatment possibility for vascular skin lesions. Dermatol Surg 1998;
24:743-748.
Background: Up to now, vascular diseases were
treated with various lasers, such as argon, pulsed dye, and copper vapor lasers,
which can lead to side effects like hypopigmentations, hyperpigmentations, and
scarring. We treated patients with vascular lesions with an incoherent intense
light source, the PhotoDerm VL-flashlamp.
Objective: The aim of the study was to test the
effectiveness and safety of the PhotoDerm VL for vascular skin lesions.
Methods: One hundred and twenty patients with
facial or leg telangiectasias, spider nevi, erythrosis interfollicularis, and
senile angiomas were treated with the PhotoDerm VL.
Results: In 73.6% of patients there was an
immediate clearing, and in 84.3% a clearing after 1 month was found of leg
telangiectasias up to 1 mm in diameter. Facial telangiectasias and erythrosis
interfollicularis colli showed clearance up to 90%. Spider nevi and senile
angiomas often only needed to be treated once.
Conclusion: From our experience we conclude that
the PhotoDerm VL is an excellent device to treat vascular lesions as there were
hardly any side effects seen, however, the user needs a sufficient experience to
get good results.
|
|
|
|
Address: 3883 Hwy 7 West, Unit 209, Woodbridge, Toronto, Ontario, Canada
Tel: 905 265 7552, Email: info@celluline.ca
|